Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist device
- 13 August 2020
- journal article
- case report
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (11) , 3202-3204
Abstract
Patients with durable left ventricular assist devices pose special problems for management in the setting of COVID‐19 infection. We describe the successful management of a 44‐year‐old man with severe COVID‐19 infection and HeartMate 3 left ventricular assist device. His course was complicated by cytokine storm and COVID‐19‐associated coagulopathy. We describe our institutional protocol for managing COVID‐19 infection in patients on mechanical circulatory support, focusing on the need for a thoughtful, multidisciplinary approach.Keywords
This publication has 8 references indexed in Scilit:
- Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist deviceJournal of Cardiac Surgery, 2020
- Supportive Treatment with Tocilizumab for COVID-19: A Systematic ReviewJournal of Clinical Virology, 2020
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the pastJournal of Clinical Virology, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Choosing the best antithrombotic regimen in patients with ventricular assist devicesCurrent Opinion in Cardiology, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Acquired coagulopathy in patients with left ventricular assist devicesJournal of Thrombosis and Haemostasis, 2018